PLAY PODCASTS
Science Extra: One semaglutide please

Science Extra: One semaglutide please

If there’s one medication that’s got everyone talking it’s the antidiabetic medication semaglutide. The drug is often better known by one of its brand names, Ozempic, and it’s exploded in popularity mainly because of its weight loss effects. So what’s happened due to the popularity and what could be coming next? Also, while COVID has become less relevant in everyday discussions it certainly hasn’t gone away. We haven’t seen the rise of a major new variant, but SARS-CoV-2 hasn’t been sitting still. This week we’re joined by health reporters Tegan Taylor and Paige Cockburn.

The Science Show · Australian Broadcasting Corporation

January 6, 202419m 6s

Audio is streamed directly from the publisher (mediacore-live-production.akamaized.net) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

If there’s one medication that’s got everyone talking it’s the antidiabetic medication semaglutide. The drug is often better known by one of its brand names, Ozempic, and it’s exploded in popularity mainly because of its weight loss effects. So what’s happened due to the popularity and what could be coming next?

Also, while COVID has become less relevant in everyday discussions it certainly hasn’t gone away. We haven’t seen the rise of a major new variant, but SARS-CoV-2 hasn’t been sitting still. 

This week we’re joined by health reporters Tegan Taylor and Paige Cockburn.